Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2018-03-23

New measures to avoid valproate exposure in pregnancy endorsed

View source ↗

Summary

EU endorses new measures to avoid valproate exposure in pregnancy, reinforcing restrictions due to teratogenic risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valproate (valproic acid, valproate semisodium) (valproate)